Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06157840 · ClinicalTrials.gov registry record · NA

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

A NA study of Opioid Use Disorder and Poor Quality Sleep, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06157840: Recruiting NA study of Opioid Use Disorder and Poor Quality Sleep, sponsored by Medical University of South Carolina.

NCT06157840 is a NA study of Opioid Use Disorder and Poor Quality Sleep that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 40 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06157840, a NA study of Opioid Use Disorder and Poor Quality Sleep, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep interventions that address common sleep-related problems in opioid use disorder. An initial program will be built utilizing input from persons beginning medications for opioid use disorders.

Primary Outcome

To achieve a minimum enrollment and retention percentage of 75% throughout the 6-week investigation period.

Interventions

  • DEVICE mHealth application and sleep health education
  • DEVICE Simplified mHealth application and sleep health education

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-08-25
Est. Completion 2026-07-17
Phase NA

What NCT06157840 shows while recruiting

NCT06157840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which mHealth application and sleep health education is the first listed.

NCT06157840 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06157840 about?

NCT06157840 is a clinical study titled "Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD". This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep interventions that address common sleep-related problems in opioid use disorder. An initial program will be built utilizing input from perso...

What is the current status of trial NCT06157840?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-25. Estimated completion is 2026-07-17.

What conditions does trial NCT06157840 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Poor Quality Sleep.

What interventions are being tested in trial NCT06157840?

The interventions under investigation include: mHealth application and sleep health education (DEVICE), Simplified mHealth application and sleep health education (DEVICE).

Who is sponsoring clinical trial NCT06157840?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06157840 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06157840's enrollment target sits among peer trials

40 183rd of 257 higher than 67 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06157840, the US trial registry maintained by the National Library of Medicine. NCT06157840 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.